Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

FDA approves Dupixent for moderate to severe atopic dermatitis in children aged 6-11 years

May 27, 2020

ATx-201 found safe and able to improve skin barrier function biomarkers in phase II study

May 27, 2020

IRAK-2 is a therapeutic target in atopic dermatitis and psoriasis

May 26, 2020

First-in-human characterization of RPT-193

May 26, 2020

Merck & Co. describes new SCN10A channel blockers

May 21, 2020

Results from a multicenter phase IIa study of PF-06700841 in patients with plaque psoriasis

May 18, 2020

Krystal Biotech announces positive interim data from phase I/II study of KB-105

May 15, 2020

Viela reports interim phase Ib data on VIB-7734 in cutaneous lupus erythematosus

May 14, 2020

Step Pharma identifies new CTP synthase 1 inhibitors

May 13, 2020

FDA clears IND for phase Ib/IIa study of HST-001 for androgenic alopecia

May 12, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...